Inventor · disambiguated record
Todd Golub
Also filed as: GOLUB TODD · GOLUB TODD R
23 granted patents·31 pending applications·395 citations·filing 2000–2024
94Inventor score
Files withBROAD INST INC18DANA FARBER CANCER INST INC10WHITEHEAD BIOMEDICAL INST9MASSACHUSETTS INST TECHNOLOGY4GOLUB TODD R3
Top patents by PatentIndex Score
54 records- 0195US6647341B1Methods for classifying samples and ascertaining previously unknown classesWHITEHEAD BIOMEDICAL INST·Filed 2000·Granted Nov 11, 2003·126 cites·12 claims
- 0294US6949342B2Prostate cancer diagnosis and outcome prediction by expression analysisDANA FARBER CANCER INST INC·Filed 2002·Granted Sep 27, 2005·152 cites·7 claims
- 0391US7501248B2Prostate cancer diagnosis and outcome prediction by expression analysisWHITEHEAD BIOMEDICAL INST·Filed 2005·Granted Mar 10, 2009·15 cites·8 claims
- 0490US7239986B2Methods for classifying samples and ascertaining previously unknown classesDANA FARBER CANCER INST INC·Filed 2002·Granted Jul 3, 2007·31 cites·12 claims
- 0589US10619195B2Gene-expression profiling with reduced numbers of transcript measurementsMASSACHUSETTS INST TECHNOLOGY·Filed 2012·Granted Apr 14, 2020·22 cites·49 claims
- 0688US11207278B2Agents for reversing toxic proteinopathiesBROAD INST INC·Filed 2021·Granted Dec 28, 2021·2 cites·20 claims
- 0787US7011947B2MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemiaDANA FARBER CANCER INST INC·Filed 2002·Granted Mar 14, 2006·24 cites·7 claims
- 0884US7105293B2Genetic markers for tumorsDANA FARBER CANCER INST INC·Filed 2001·Granted Sep 12, 2006·11 cites·9 claims
- 0980US7324926B2Methods for predicting chemosensitivity or chemoresistanceWHITEHEAD BIOMEDICAL INST·Filed 2001·Granted Jan 29, 2008·10 cites·7 claims
- 1073US10191033B2Biomarkers for detecting pre-cachexia or cachexia and methods of treatment thereofBROAD INST INC·Filed 2014·Granted Jan 29, 2019·1 cites·11 claims
- 1172US12048676B2Agents for reversing toxic proteinopathiesBROAD INST INC·Filed 2021·Granted Jul 30, 2024·0 cites·22 claims
- 1272US12023308B2Agents for reversing toxic proteinopathiesBROAD INST INC·Filed 2021·Granted Jul 2, 2024·0 cites·17 claims
- 1368US2025127768A1Therapeutic targeting of inositol pyrophosphate synthesis in cancerBROAD INST INC·Filed 2024·Application pending·0 cites
- 1466US11058903B2Methods for identifying and treating cachexia or pre-cachexia using an inhibitor of rageBROAD INST INC·Filed 2018·Granted Jul 13, 2021·0 cites·20 claims
- 1562US8828965B2MiR-150 for the treatment of blood disordersGEN HOSPITAL CORP·Filed 2013·Granted Sep 9, 2014·0 cites·7 claims
- 1662US2009202493A1Mir-150 for the treatment of blood disordersGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 1761US2020347444A1Gene-expression profiling with reduced numbers of transcript measurementsMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 1861US2013225432A1Solution-based methods for rna expression profilingMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 1960US8530443B2miR-150 for the treatment of blood disordersLU JUN·Filed 2012·Granted Sep 10, 2013·0 cites·5 claims
- 2060US2007065844A1Solution-based methods for RNA expression profilingDANA FARBER CANCER INST INC·Filed 2006·Application pending·0 cites
- 2159US10724099B2Multiplex methods to assay mixed cell populations simultaneouslyBROAD INST INC·Filed 2013·Granted Jul 28, 2020·1 cites·10 claims
- 2259US2006008838A1Prostate cancer diagnosis and outcome prediction by expression analysisDANA FARBER CANCER INST INC·Filed 2005·Application pending·0 cites
- 2358US2004098367A1Across platform and multiple dataset molecular classificationWHITEHEAD BIOMEDICAL INST·Filed 2003·Application pending·0 cites
- 2457US12313632B2Tepoxalin targeting of ABCB1 overexpressing cancersBROAD INST INC·Filed 2019·Granted May 27, 2025·0 cites·15 claims
- 2555US2004009495A1Methods and products related to drug screening using gene expression patternsWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 2654US12435377B2Cancers with loss of chromosome 16Q and/or low expression of metallothionein proteinsBROAD INST INC·Filed 2019·Granted Oct 7, 2025·0 cites·16 claims
- 2754US2011015080A1Solution-based methods for RNA expression profilingMASSACHUSETTS INST TECHNOLOGY·Filed 2010·Application pending·0 cites
- 2853US2003225526A1Molecular cancer diagnosis using tumor gene expression signatureFiled 2002·Application pending·0 cites
- 2953US2006057630A1MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemiaGOLUB TODD R·Filed 2005·Application pending·0 cites
- 3053US2006024734A1MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemiaGOLUB TODD R·Filed 2005·Application pending·0 cites
- 3152US2022218847A1Compositions and methods characterizing metastasisBROAD INST INC·Filed 2020·Application pending·0 cites
- 3252US2023115675A1Methods of treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 3351US2002115070A1Methods and apparatus for analyzing gene expression dataFiled 2000·Application pending·0 cites
- 3450US2023151431A1Methods and compositions for identifying and treating glutaminase inhibitor-sensitive cancersDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 3549US2013338092A1Compounds and methods for targeting leukemic stem cellsBROAD INST INC·Filed 2013·Application pending·0 cites
- 3647US2023277618A1Therapeutic targeting of phosphate dysregulation in cancer via the xpr1:kidins220 protein complexBROAD INST INC·Filed 2021·Application pending·0 cites
- 3747US2004009489A1Classification of lung carcinomas using gene expression analysisFiled 2002·Application pending·0 cites
- 3846US2003194701A1Diffuse large cell lymphoma diagnosis and outcome prediction by expression analysisFiled 2001·Application pending·0 cites
- 3946US2023075965A1Uses of biomarkers for improving immunotherapyMITSIADES CONSTANTINE S·Filed 2021·Application pending·0 cites
- 4045US11633415B2Compounds and methods useful for treating or preventing cancersBROAD INST INC·Filed 2018·Granted Apr 25, 2023·0 cites·15 claims
- 4143US12297426B2DNA damage response signature guided rational design of CRISPR-based systems and therapiesBROAD INST INC·Filed 2021·Granted May 13, 2025·0 cites·22 claims
- 4243US9890429B2Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancerDANA FARBER CANCER INST INC·Filed 2013·Granted Feb 13, 2018·0 cites·20 claims
- 4343US2011263693A1Celastrol, gedunin, and derivatives thereof as hsp90 inhibitorsDANA FARBER CANCER INST INC·Filed 2007·Application pending·0 cites
- 4442US12358918B2Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeuticsBROAD INST INC·Filed 2019·Granted Jul 15, 2025·0 cites·3 claims
- 4542US2002155480A1Brain tumor diagnosis and outcome predictionFiled 2002·Application pending·0 cites
- 4642US2004010481A1Time-dependent outcome prediction using neural networksWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 4742US2003087865A1Leukemogenic transcription factorsWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 4841US2011263441A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disordersGOLUB TODD R·Filed 2009·Application pending·0 cites
- 4940US11111296B2Compositions and methods for treating cardiac dysfunctionBROAD INST INC·Filed 2016·Granted Sep 7, 2021·0 cites·7 claims
- 5040US2001044414A1Metastasis genes and uses thereofWHITEHEAD BIOMEDICAL INST·Filed 2000·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Todd Golub files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →